PATHOPHYSIOLOGY OF ATM & P53
ATM 的病理生理学
基本信息
- 批准号:7720212
- 负责人:
- 金额:$ 2.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAtaxia-Telangiectasia-Mutated protein kinaseCell CycleCollaborationsComputer Retrieval of Information on Scientific Projects DatabaseDNA DamageDNA RepairFunctional disorderFundingGoalsGrantGrowth FactorInstitutionInsulin ResistanceNerve DegenerationPhysiological ProcessesPlant ExtractsProcessProtein p53ProteinsResearchResearch PersonnelResourcesSignal TransductionSourceStressTP53 geneTeton Sioux IndianTranslation InitiationTranslationsUnited States National Institutes of HealthYangataxia telangiectasia mutated proteincell typecollegecytotoxicdiabetic ratresponse
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Dr. Yang studies signal transduction of growth factors and the mechanism of protein translation initiation. His research focuses on two important proteins, ATM and p53, which are critical for multiple physiological processes such as cell cycle progress, DNA damage repair, neuronal degeneration, and insulin resistance. His goal is to understand how ATM kinase functions in various types of cells in response to growth factors and cytotoxic stresses. He also examines how translation of p53 tumor suppressor is regulated in response to DNA damage signals Dr. Yang will be carrying out a collaborative study with Dr. Sandoval from Oglala Lakota College on the effects of the plant extract on diabetic rats. The purchase of animals and supplies for this collaboration is in process.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
博士杨博士研究生长因子的信号转导和蛋白质翻译起始的机制。他的研究主要集中在两个重要的蛋白质,ATM和p53,这是关键的多个生理过程,如细胞周期的进展,DNA损伤修复,神经元变性和胰岛素抵抗。他的目标是了解ATM激酶如何在各种类型的细胞中响应生长因子和细胞毒性应激而发挥作用。他还研究了p53肿瘤抑制因子的翻译是如何响应DNA损伤信号进行调节的。杨博士将与奥格拉拉拉科塔学院的桑多瓦尔博士合作研究植物提取物对糖尿病大鼠的影响。 为这项合作购买动物和用品的工作正在进行中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Da-Qing Yang其他文献
Da-Qing Yang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Da-Qing Yang', 18)}}的其他基金
Modulation of p53 induction by targeting cap-dependent translation in cancer
通过靶向癌症中帽依赖性翻译来调节 p53 诱导
- 批准号:
8640123 - 财政年份:2013
- 资助金额:
$ 2.87万 - 项目类别:
Modulation of p53 induction by targeting cap-dependent translation in cancer
通过靶向癌症中帽依赖性翻译来调节 p53 诱导
- 批准号:
8565086 - 财政年份:2013
- 资助金额:
$ 2.87万 - 项目类别:
Defective p53 synthesis following DNA damage and cancer development
DNA 损伤和癌症发展后 p53 合成缺陷
- 批准号:
7773947 - 财政年份:2010
- 资助金额:
$ 2.87万 - 项目类别:
Defective p53 synthesis following DNA damage and cancer development
DNA 损伤和癌症发展后 p53 合成缺陷
- 批准号:
8369382 - 财政年份:2010
- 资助金额:
$ 2.87万 - 项目类别:
IDENTIFICATION OF ATM TARGETS BY PROTEOMIC ANALYSIS IN SH-SY5Y NEURON-LIKE CELLS
通过 SH-SY5Y 神经元样细胞中的蛋白质组学分析鉴定 ATM 靶标
- 批准号:
7959613 - 财政年份:2009
- 资助金额:
$ 2.87万 - 项目类别:
ATM IN NEURONAL DIFFERENTIATION IN RESPONSE TO INSULIN
ATM 在胰岛素反应中的神经元分化
- 批准号:
7011702 - 财政年份:2004
- 资助金额:
$ 2.87万 - 项目类别:














{{item.name}}会员




